We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$830M
AUM Growth
+$70.8M
Cap. Flow
+$31.3M
Cap. Flow %
3.77%
Top 10 Hldgs %
42.39%
Holding
84
New
4
Increased
26
Reduced
27
Closed
6

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$28.2M
2
AMD icon
Advanced Micro Devices
AMD
+$25.5M
3
MCK icon
McKesson
MCK
+$21.9M
4
TER icon
Teradyne
TER
+$19M
5
INTU icon
Intuit
INTU
+$16.9M

Sector Composition

Rank Sector Weight
1 Technology 32.99%
2 Consumer Discretionary 16.28%
3 Healthcare 14.61%
4 Financials 12.87%
5 Communication Services 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSG icon
26
Republic Services
RSG
$66.7B
$14.1M 1.7%
61,498
+17,640
+40% +$4.14M
LULU icon
27
lululemon athletica
LULU
$13B
$10.7M 1.29%
+60,125
New +$12M
BX icon
28
Blackstone
BX
$104B
$9.82M 1.18%
57,450
-7,500
-12% -$1.28M
V icon
29
Visa
V
$677B
$8.07M 0.97%
23,648
+321
+1% +$111K
ONON icon
30
On Holding
ONON
$11.9B
$7.84M 0.95%
185,200
+57,700
+45% +$2.75M
MA icon
31
Mastercard
MA
$477B
$7.84M 0.94%
13,782
+30
+0.2% +$17.2K
BABA icon
32
Alibaba
BABA
$269B
$6.79M 0.82%
38,000
-115,000
-75% -$15.1M
ETN icon
33
Eaton
ETN
$157B
$6.75M 0.81%
18,040
+4,400
+32% +$1.6M
ABBV icon
34
AbbVie
ABBV
$458B
$6.24M 0.75%
26,939
+62
+0.2% +$12.6K
GOOGL icon
35
Alphabet (Google) Class A
GOOGL
$3.91T
$5.11M 0.62%
21,024
-47,990
-70% -$10.1M
TMO icon
36
Thermo Fisher Scientific
TMO
$211B
$5.09M 0.61%
10,485
-200
-2% -$93.1K
DHR icon
37
Danaher
DHR
$135B
$4.21M 0.51%
21,237
-875
-4% -$174K
JPM icon
38
JPMorgan Chase
JPM
$939B
$3.01M 0.36%
9,548
+40
+0.4% +$11.9K
INDA icon
39
iShares MSCI India ETF
INDA
$6.71B
$2.81M 0.34%
54,000
ADBE icon
40
Adobe
ADBE
$89.5B
$2.52M 0.3%
7,135
-1,885
-21% -$676K
CHD icon
41
Church & Dwight Co
CHD
$23.1B
$2.47M 0.3%
28,177
-500
-2% -$46.9K
MU icon
42
Micron Technology
MU
$1.04T
$2.37M 0.29%
14,190
-133,150
-90% -$17M
PG icon
43
Procter & Gamble
PG
$343B
$2.26M 0.27%
14,735
-50
-0.3% -$7.81K
CRM icon
44
Salesforce
CRM
$134B
$2.18M 0.26%
9,214
-4,005
-30% -$1.01M
AMT icon
45
American Tower
AMT
$77.7B
$2.13M 0.26%
11,100
PANW icon
46
Palo Alto Networks
PANW
$264B
$2.08M 0.25%
10,195
-525
-5% -$100K
ANET icon
47
Arista Networks
ANET
$219B
$1.99M 0.24%
13,628
-200
-1% -$25.8K
VRTX icon
48
Vertex Pharmaceuticals
VRTX
$121B
$1.97M 0.24%
5,025
-43,740
-90% -$18.3M
EW icon
49
Edwards Lifesciences
EW
$47.6B
$1.48M 0.18%
19,031
+115
+0.6% +$8.98K
MAS icon
50
Masco
MAS
$16B
$1.25M 0.15%
17,801

Similar funds

De Burlo Group's Q3 2025 Portfolio in Review

As of Q3 2025, De Burlo Group held 84 positions worth $830M, up 9.3% from $759M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

De Burlo Group deployed $31.3M of net new capital in Q3 2025, opening 4 new positions and adding to 26 existing holdings. Its largest new stake was Novo Nordisk: 481,160 shares worth $26.7M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $18.3M trimmed.

  • De Burlo Group's largest Q3 2025 buy was Novo Nordisk: 481,160 shares worth $26.7M.
  • De Burlo Group added most to Advanced Micro Devices in Q3 2025, an estimated $25.5M increase.
  • De Burlo Group's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $18.3M.
  • De Burlo Group fully exited Intuitive Surgical in Q3 2025, selling an estimated $19.5M.
  • De Burlo Group's ten largest holdings make up 42% of its $830M portfolio in Q3 2025.
  • De Burlo Group opened 4 new positions and closed 6 in Q3 2025.
  • De Burlo Group's portfolio value rose 9.3% quarter-over-quarter to $830M.

Based on De Burlo Group's 13F filing for Q3 2025, filed 13 Nov 2025.